High demand for at-home COVID tests could hamper supply
(HealthDay)—Demand for Abbott Laboratories' at-home COVID-19 tests has reached "unprecedented" levels and supply may be limited in the coming weeks, the company says.
Aug 30, 2021
0
3
(HealthDay)—Demand for Abbott Laboratories' at-home COVID-19 tests has reached "unprecedented" levels and supply may be limited in the coming weeks, the company says.
Aug 30, 2021
0
3
Inoculating the planet from COVID-19 presents an unprecedented logistical challenge like none we've seen before. Mobilizing for a world war may be the closest comparison—but in this case, the enemy is invisible and everywhere.
Aug 24, 2021
0
13
Covax is expecting to receive 250 million donated COVID-19 vaccine doses over the next six to eight weeks, the World Health Organization said Wednesday.
Jul 28, 2021
0
165
Drugmaker AstraZeneca said Saturday it was scouring its supply chain to find more doses of its COVID-19 vaccine for Southeast Asia, which is facing its most serious outbreak yet of the virus.
Jul 24, 2021
0
1
To prepare for the next pandemic and provide a coordinated approach to vaccination across the country, Canada should create Canadian Immunization Services based on the Canadian Blood Services model, authors propose in CMAJ ...
Jul 19, 2021
0
1
Deteriorating living and working conditions for workers in garment supply chains during the COVID-19 pandemic have increased the risk of forced labour, according to a new report from the University of Sheffield.
Jun 21, 2021
0
1
A new method to analyze the blood thinning drug heparin has been developed that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.
May 14, 2021
0
2
The International Federation of Pharmaceutical Manufacturers and Associations expressed disappointment Wednesday at the United States' decision to support a global waiver on patent protections for Covid-19 vaccines.
May 6, 2021
0
4
Activists cheered, Big Pharma complained and government leaders assessed next steps on Thursday after the Biden administration's blockbuster move to support an easing of patent and other protections on COVID-19 vaccines that ...
May 6, 2021
0
2
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Apr 28, 2021
0
1